Learning Objectives:

1.  Discuss results of lecanemab and donanemab.

2.  Evaluate the role of amyloid in Alzheimer's disease.

3.

Session date: 
03/12/2024 - 8:00am to 9:00am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Chad Yucus, MD